metformin has been researched along with agmatine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Best, L; Bjedov, I; Bryson, K; Cabreiro, F; Cochemé, HM; De Haes, W; Esser, D; Franke, A; Houtkooper, RH; Kaleta, C; Laudes, M; Lieb, W; Lujan, C; Marinos, G; Martinez-Martinez, D; Norvaisas, P; Pryor, R; Quintaneiro, LM; Scott, TA; Smith, RL; Temmerman, L; Thingholm, LB; Waschina, S; Woodward, O | 1 |
2 other study(ies) available for metformin and agmatine
Article | Year |
---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy.
Topics: Agmatine; Animals; Caenorhabditis elegans; Cyclic AMP Receptor Protein; Diabetes Mellitus, Type 2; Escherichia coli; Gastrointestinal Microbiome; Host Microbial Interactions; Humans; Hypoglycemic Agents; Lipid Metabolism; Longevity; Metformin; Nutrients | 2019 |